SEC 13F Intelligence

Managers / Q1 2026

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$132M
Q1 2026
Positions
34
Filings on Record
30
2019–present window
Filed
Apr 15, 2026
original filing

Summary

Sivik Global Healthcare LLC reported $132M in U.S.-listed holdings across 34 positions for Q1 2026.

Its largest position, XBI, represents 14.5% of the portfolio.

Compared with Q4 2025, the fund opened 7 new positions and exited 22.

Portfolio Metrics

Turnover
+11.1%
vs prior filed quarter
Top-10 Concentration
+46.6%
share of reported value
Largest Position
+14.5%
State Street Spdr S P Biotech
New / Exited
7 / 22
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 80.4%ETP: 14.5%Other: 3.8%ADR: 1.2%
  • Common Stock · 80.4% · $106M
  • ETP · 14.5% · $19M
  • Other · 3.8% · $5M
  • ADR · 1.2% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
CALL- BSX 100 @ 75 EXP 04/17/2026NEW+800800+$5M$5M
JNJJOHNSON&JOHNSONNEW+20.0K20.0K+$5M$5M
WATWATERS CORPNEW+15.0K15.0K+$4M$4M
AZNASTRAZENECA PLCNEW+20.0K20.0K+$4M$4M
REGNREGENERON PHARMACEUTICALSNEW+4.0K4.0K+$3M$3M
ELVELEVANCE HEALTH INCNEW+5.0K5.0K+$1M$1M
CVSCVS HEALTH CORPNEW+20.0K20.0K+$1M$1M
PUT - SPY 100 @ 684 EXP 01/30/2026SOLD OUT−3000−$20M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

34 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISTATE STREET SPDR S&P BIOTECHhistory →S&P BIOTECH14.55%$19M150.0K
2CAHCARDINAL HEALTHhistory →COM3.85%$5M24.0K
3CALL- BSX 100 @ 75 EXP 04/17/2026CALL3.81%$5M800
4JNJJOHNSON&JOHNSONhistory →COM3.71%$5M20.0K
5MRKMERCK & COhistory →COM3.65%$5M40.0K
6CORCENCORA INChistory →COM3.58%$5M15.0K
7LLYELI LILLY & COhistory →COM3.49%$5M5.0K
8WATWATERS CORPhistory →COM3.39%$4M15.0K
9VRTXVERTEX PHARMACEUTICALS INC.history →COM3.39%$4M10.0K
10ISRGINTUITIVE SURGhistory →COM NEW3.15%$4M9.0K
11AZNASTRAZENECA PLChistory →ORD3.00%$4M20.0K
12TMOTHERMO FISHER SCIENTIFIC INC.history →COM2.99%$4M8.0K
13BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM2.95%$4M62.0K
14DHRDANAHER CORPhistory →COM2.88%$4M20.0K
15THCTENET HEALTHCAREhistory →COM NEW2.87%$4M20.0K
16GILDGILEAD SCIENCES INChistory →COM2.65%$3M25.0K
17HUMHUMANA INC.history →COM2.63%$3M20.0K
18MTDMETTLER TOLEDOhistory →COM2.63%$3M2.8K
19MCKMCKESSON CORPhistory →COM2.63%$3M4.0K
20AAGILENT TECHNOLOGIES INChistory →COM2.60%$3M30.0K
21SYKSTRYKER CORPhistory →COM2.50%$3M10.0K
22ABBVABBVIE INChistory →COM2.48%$3M15.0K
23UHSUNIV HEALTH SVChistory →CLASS B2.38%$3M17.5K
24REGNREGENERON PHARMACEUTICALShistory →COM2.35%$3M4.0K
25BIOBIO-RAD LABS Ahistory →CL A2.12%$3M10.0K
26BIIBBIOGEN INChistory →COM2.09%$3M15.0K
27UNHUNITEDHEALTH GRPhistory →COM2.05%$3M10.0K
28GMEDGLOBUS MEDICALhistory →CL A1.96%$3M30.0K
29ABTABBOTT LABShistory →COM1.95%$3M25.0K
30EWEDWARDS LIFESCIENCEShistory →COM1.22%$2M20.0K
31SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.21%$2M50.0K
32ELVELEVANCE HEALTH INChistory →COM1.11%$1M5.0K
33EHCENCOMPASS HEALTH CORPhistory →COM1.10%$1M15.0K
34CVSCVS HEALTH CORPhistory →COM1.09%$1M20.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.